About this Journal Submit a Manuscript Table of Contents
Journal of Oncology
Volume 2012 (2012), Article ID 863747, 10 pages
http://dx.doi.org/10.1155/2012/863747
Review Article

Optical Imaging in Breast Cancer Diagnosis: The Next Evolution

1Molecular Imaging Program, PET Radiopharmacy Unit, Molecular Imaging Group, IDIS, GALARIA-SERGAS, University Hospital Complex, Travesía de Choupana s/n., 15706 Santiago de Compostela, Spain
2Nuclear Medicine Service, Medicine Faculty, Molecular Imaging Group, IDIS, University Hospital Complex, Travesía de Choupana s/n., 15706 Santiago de Compostela, Spain

Received 21 June 2012; Accepted 28 August 2012

Academic Editor: José María Benlloch

Copyright © 2012 Michel Herranz and Alvaro Ruibal. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Garcia, A. Jemal, E. M. Ward et al., Global Cancer Facts & Figures 2007, American Cancer Society, Atlanta, Ga, USA, 2007.
  2. American cancer Society, Statistics for 2004: Cancer facts & figures, 2004, http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/index.
  3. S. A. Feig, “Decreased breast cancer mortality through mammographic screening: results of clinical trials,” Radiology, vol. 167, no. 3, pp. 659–665, 1988. View at Scopus
  4. “Breast cancer. Early detection and prompt treatment are critical,” Mayo Clinic Health Letter, supplement 1–8, 2001.
  5. S. L. Jacques, “Time resolved propagation of ultrashort laser pulses within turbid tissues,” Applied Optics, vol. 28, no. 12, pp. 2223–2229, 1989.
  6. K. Kerlikowske, J. Barclay, D. Grady, E. A. Sickles, and V. Ernster, “Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer,” Journal of the National Cancer Institute, vol. 89, no. 1, pp. 77–82, 1997. View at Scopus
  7. M. J. Homer, “Breast imaging: pitfalls, controversies, and some practical thoughts,” Radiologic Clinics of North America, vol. 23, no. 3, pp. 459–472, 1985. View at Scopus
  8. J. Wang, T. T. F. Shih, J. C. Y. Hsu, and Y. W. Li, “The evaluation of false negative mammography from malignant and benign breast lesions,” Clinical Imaging, vol. 24, no. 2, pp. 96–103, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Shapiro, P. Strax, and L. Venet, “Periodic breast cancer screening in reducing mortality from breast cancer,” Journal of the American Medical Association, vol. 215, no. 11, pp. 1777–1785, 1971. View at Publisher · View at Google Scholar · View at Scopus
  10. E. L. Thurfjell and J. A. Lindgren, “Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years,” Radiology, vol. 201, no. 2, pp. 421–426, 1996. View at Scopus
  11. R. E. Hendrick, R. A. Smith, J. H. Rutledge III, and C. R. Smart, “Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials,” Journal of the National Cancer Institute Monographs, no. 22, pp. 87–92, 1997. View at Scopus
  12. L. Tabar, B. Vitak, H. H. Chen, M. F. Yen, S. W. Duffy, and R. A. Smith, “Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality,” Cancer, vol. 91, no. 9, pp. 1724–1731, 2001.
  13. J. M. Boone, “Normalized glandular dose (DgN) coefficients for arbitrary x-ray spectra in mammography: computer-fit values of Monte Carlo derived data,” Medical Physics, vol. 29, no. 5, pp. 869–875, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. G. R. Hammsterstein, D. W. Miller, and D. R. White, “Absorbed radiation dose in mammography,” Radiology, vol. 130, no. 2, pp. 485–491, 1979. View at Scopus
  15. T. M. Kolb, J. Lichy, and J. H. Newhouse, “Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations,” Radiology, vol. 225, no. 1, pp. 165–175, 2002. View at Scopus
  16. FDA, US Public Health Advisory: Update on Magnetic Resonance Imaging (MRI) Contrast Agents Containing Gadolinium and Nephrogenic Fibrosing Dermopathy, 2006, http://www.fda.gov/Cder/Drug/advisory/gadolinium(agents)20061222.htm.
  17. I. S. Gribbestad, B. Sitter, S. Lundgren, J. Krane, and D. Axelson, “Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy,” Anticancer Research, vol. 19, no. 3, pp. 1737–1746, 1999. View at Scopus
  18. K. Yutani, E. Shiba, H. Kusuoka et al., “Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis,” Journal of Computer Assisted Tomography, vol. 24, no. 2, pp. 274–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. F. Smith, S. Majewski, A. G. Weisenberger, D. A. Kieper, R. R. Raylman, and T. G. Turkington, “Analysis of factors affecting positron emission mammography (PEM) image formation,” IEEE Transactions on Nuclear Science, vol. 50, no. 1, pp. 53–59, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. J. Thompson, K. Murthy, I. N. Weinberg, and F. Mako, “Feasibility study for positron emission mammography,” Medical Physics, vol. 21, no. 4, pp. 529–538, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Cutler, “Transillumination of the breast,” Surgery, Gynecology & Obstetrics, vol. 48, pp. 721–727, 1929.
  22. D. Floery, T. H. Helbich, C. C. Riedl et al., “Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience,” Investigative Radiology, vol. 40, no. 6, pp. 328–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Ntziachristos, A. G. Yodh, M. D. Schnall, and B. Chance, “MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions,” Neoplasia, vol. 4, no. 4, pp. 347–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. B. J. Tromberg, A. Cerussi, N. Shah et al., “Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy,” Breast Cancer Research, vol. 7, no. 6, pp. 279–285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Zhu, E. B. Cronin, A. A. Currier et al., “Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction,” Radiology, vol. 237, no. 1, pp. 57–66, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Leff, O. J. Warren, L. C. Enfield et al., “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Research and Treatment, vol. 108, no. 1, pp. 9–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Poellinger, J. C. Martin, S. L. Ponder et al., “Near-infrared laser computed tomography of the breast. First clinical experience,” Academic Radiology, vol. 15, no. 12, pp. 1545–1553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Floery, T. H. Helbich, C. C. Riedl et al., “Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience,” Investigative Radiology, vol. 40, no. 6, pp. 328–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. L. S. Fournier, D. Vanel, A. Athanasiou et al., “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” European Journal of Radiology, vol. 69, no. 1, pp. 43–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. W. Y. Van De Ven, N. Mincu, J. Brunette et al., “Molecular imaging using light-absorbing imaging agents and a clinical optical breast imaging system—a phantom study,” Molecular Imaging and Biology, vol. 13, no. 2, pp. 232–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. R. Arridge and M. Schweiger, “Image reconstruction in optical tomography,” Philosophical Transactions of the Royal Society B, vol. 352, no. 1354, pp. 717–726, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Schweiger, I. Nissilä, D. A. Boas, and S. R. Arridge, “Image reconstruction in optical tomography in the presence of coupling errors,” Applied Optics, vol. 46, no. 14, pp. 2743–2756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Siegel, J. J. A. Marota, and D. A. Boas, “Design and evaluation of a continuous-wave diffuse optical tomography system,” Optics Express, vol. 4, no. 8, pp. 287–298, 1999. View at Scopus
  34. P. Taroni, A. Torricelli, L. Spinelli et al., “Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions,” Physics in Medicine and Biology, vol. 50, no. 11, pp. 2469–2488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. P. Gibson, J. C. Hebden, and S. R. Arridge, “Recent advances in diffuse optical imaging,” Physics in Medicine and Biology, vol. 50, no. 4, pp. R1–R43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Rice and C. M. Quinn, “Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast,” Journal of Clinical Pathology, vol. 55, no. 8, pp. 569–574, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Vaupel and L. Harrison, “Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response,” Oncologist, vol. 9, no. 5, pp. 4–9, 2004. View at Scopus
  38. L. Gotz, S. H. Heywang-Kobrunner, O. Schutz, and H. Siebold, “Optical mammography on preoperative patients,” Aktuelle Radiologie, vol. 8, no. 1, pp. 31–33, 1998. View at Scopus
  39. D. Floery, T. H. Helbich, C. C. Riedl et al., “Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience,” Investigative Radiology, vol. 40, no. 6, pp. 328–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Academic Radiology, vol. 11, no. 1, pp. 53–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. Q. Zhu, E. B. Cronin, A. A. Currier et al., “Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction,” Radiology, vol. 237, no. 1, pp. 57–66, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Bremer, V. Ntziachristos, B. Weitkamp, G. Theilmeier, W. Heindel, and R. Weissleder, “Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes,” Investigative Radiology, vol. 40, no. 6, pp. 321–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Bremer, C. H. Tung, A. Bogdanov, and R. Weissleder, “Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes,” Radiology, vol. 222, no. 3, pp. 814–818, 2002. View at Scopus
  44. I. Hilger, Y. Leistner, A. Berndt et al., “Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells,” European Radiology, vol. 14, no. 6, pp. 1124–1129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Ke, X. Wen, M. Gurfinkel et al., “Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts,” Cancer Research, vol. 63, no. 22, pp. 7870–7875, 2003. View at Scopus
  46. V. Ntziachristos, A. G. Yodh, M. Schnall, and B. Chance, “Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 6, pp. 2767–2772, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Licha, B. Riefke, V. Ntziachristos, A. Becker, B. Chance, and W. Semmler, “Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization,” Photochemistry and Photobiology, vol. 72, pp. 392–398, 2000.
  48. V. Ntziachristos, A. G. Yodh, M. Schnall, and B. Chance, “Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 6, pp. 2767–2772, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Corlu, R. Choe, T. Durduran et al., “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Optics Express, vol. 15, no. 11, pp. 6696–6716, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Achilefu, R. B. Dorshow, J. E. Bugaj, and R. Rajagopalan, “Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging,” Investigative Radiology, vol. 35, no. 8, pp. 479–485, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Weissleder, C. H. Tung, U. Mahmood, and A. Bogdanov, “In vivo imaging of tumors with protease-activated near-infrared fluorescent probes,” Nature Biotechnology, vol. 17, no. 4, pp. 375–378, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. T. A. Giambernardi, G. M. Grant, G. P. Taylor et al., “Overview of matrix metalloproteinase expression in cultured human cells,” Matrix Biology, vol. 16, no. 8, pp. 483–496, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. J. V. Frangioni, “In vivo near-infrared fluorescence imaging,” Current Opinion in Chemical Biology, vol. 7, no. 5, pp. 626–634, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Tanaka, H. S. Choi, H. Fujii, M. G. Bawendi, and J. V. Frangioni, “Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping,” Annals of Surgical Oncology, vol. 13, no. 12, pp. 1671–1681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. D. W. Knapp, L. G. Adams, A. M. DeGrand et al., “Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light,” European Urology, vol. 52, no. 6, pp. 1700–1708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. C. P. Parungo, D. I. Soybel, Y. L. Colson et al., “Lymphatic drainage of the peritoneal space: a pattern dependent on bowel lymphatics,” Annals of Surgical Oncology, vol. 14, no. 2, pp. 286–298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. J. L. Figueiredo, H. Alencar, R. Weissleder, and U. Mahmood, “Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer,” International Journal of Cancer, vol. 118, no. 11, pp. 2672–2677, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Tanaka, S. Ohnishi, R. G. Laurence, H. S. Choi, V. Humblet, and J. V. Frangioni, “Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence,” Journal of Urology, vol. 178, no. 5, pp. 2197–2202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. P. A. Carney, D. L. Miglioretti, B. C. Yankaskas, et al., “Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography,” Annals of Internal Medicine, vol. 138, pp. 168–175, 2003.
  60. N. F. Boyd, H. Guo, L. J. Martin et al., “Mammographic density and the risk and detection of breast cancer,” New England Journal of Medicine, vol. 356, no. 3, pp. 227–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Debbage and W. Jaschke, “Molecular imaging with nanoparticles: giant roles for dwarf actors,” Histochemistry and Cell Biology, vol. 130, no. 5, pp. 845–875, 2008. View at Publisher · View at Google Scholar · View at Scopus